Early glaucoma risk screening shows promise for Australian populations
Researchers at QIMR Berghofer and Flinders University developed a polygenic risk score test using genetic data from 6 million people—including 300,000 diagnosed with glaucoma—to identify individuals with significantly elevated risk. For Australians of European ancestry, the highest genetic risk group had 10 times the likelihood of developing glaucoma compared to the general population. This test focuses on early intervention for open-angle glaucoma, the leading cause of global blindness. While the research was published in *Ophthalmology*, clinical implementation for widespread screening remains pending cost-effectiveness studies. The test’s accuracy for non-European populations requires further validation, and current use is limited to research contexts. If scaled, it could prevent irreversible vision loss by enabling treatment before optic nerve damage occurs—reducing blindness-related costs and preserving quality of life for high-risk groups. The source notes this is not yet a general screening tool and ethnic applicability is an active research priority.
Source: New Atlas
Many Minded